Roivant Sciences (ROIV) Total Debt (2021 - 2024)

Roivant Sciences (ROIV) has 4 years of Total Debt data on file, last reported at $323.7 million in Q2 2024.

• Quarterly Total Debt fell 17.51% year-over-year to $323.7 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $323.7 million (down 17.51% YoY) and the FY2024 annual result came in at $442.6 million, up 6.33% from the prior year.
• Total Debt retreated to $323.7 million in Q2 2024, from $442.6 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $442.6 million in Q1 2024 to a low of $170.3 million in Q1 2021.
• A 4-year average of $327.7 million and a median of $390.9 million in 2022 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2022 — Total Debt soared 109.85% — and 2024, when it dropped 17.51%.
• Tracing ROIV's Total Debt over 4 years: stood at $204.0 million in 2021, then surged by 94.64% to $397.2 million in 2022, then gained by 7.1% to $425.4 million in 2023, then fell by 23.9% to $323.7 million in 2024.
• The last three Total Debt figures came in at $323.7 million (Q2 2024), $442.6 million (Q1 2024), and $425.4 million (Q4 2023), per Business Quant data.